Cargando…

Corrigendum: Dauricine attenuates vascular endothelial inflammation through inhibiting NF-κB pathway

Detalles Bibliográficos
Autores principales: Hu, Ji, Chen, Ru, An, Jie, Wang, Yilong, Liang, Minglu, Huang, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470825/
https://www.ncbi.nlm.nih.gov/pubmed/37663242
http://dx.doi.org/10.3389/fphar.2023.1236892
_version_ 1785099768077221888
author Hu, Ji
Chen, Ru
An, Jie
Wang, Yilong
Liang, Minglu
Huang, Kai
author_facet Hu, Ji
Chen, Ru
An, Jie
Wang, Yilong
Liang, Minglu
Huang, Kai
author_sort Hu, Ji
collection PubMed
description
format Online
Article
Text
id pubmed-10470825
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104708252023-09-01 Corrigendum: Dauricine attenuates vascular endothelial inflammation through inhibiting NF-κB pathway Hu, Ji Chen, Ru An, Jie Wang, Yilong Liang, Minglu Huang, Kai Front Pharmacol Pharmacology Frontiers Media S.A. 2023-08-17 /pmc/articles/PMC10470825/ /pubmed/37663242 http://dx.doi.org/10.3389/fphar.2023.1236892 Text en Copyright © 2023 Hu, Chen, An, Wang, Liang and Huang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Hu, Ji
Chen, Ru
An, Jie
Wang, Yilong
Liang, Minglu
Huang, Kai
Corrigendum: Dauricine attenuates vascular endothelial inflammation through inhibiting NF-κB pathway
title Corrigendum: Dauricine attenuates vascular endothelial inflammation through inhibiting NF-κB pathway
title_full Corrigendum: Dauricine attenuates vascular endothelial inflammation through inhibiting NF-κB pathway
title_fullStr Corrigendum: Dauricine attenuates vascular endothelial inflammation through inhibiting NF-κB pathway
title_full_unstemmed Corrigendum: Dauricine attenuates vascular endothelial inflammation through inhibiting NF-κB pathway
title_short Corrigendum: Dauricine attenuates vascular endothelial inflammation through inhibiting NF-κB pathway
title_sort corrigendum: dauricine attenuates vascular endothelial inflammation through inhibiting nf-κb pathway
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470825/
https://www.ncbi.nlm.nih.gov/pubmed/37663242
http://dx.doi.org/10.3389/fphar.2023.1236892
work_keys_str_mv AT huji corrigendumdauricineattenuatesvascularendothelialinflammationthroughinhibitingnfkbpathway
AT chenru corrigendumdauricineattenuatesvascularendothelialinflammationthroughinhibitingnfkbpathway
AT anjie corrigendumdauricineattenuatesvascularendothelialinflammationthroughinhibitingnfkbpathway
AT wangyilong corrigendumdauricineattenuatesvascularendothelialinflammationthroughinhibitingnfkbpathway
AT liangminglu corrigendumdauricineattenuatesvascularendothelialinflammationthroughinhibitingnfkbpathway
AT huangkai corrigendumdauricineattenuatesvascularendothelialinflammationthroughinhibitingnfkbpathway